TGA approves first pharma option for proliferative diabetic retinopathy For 40 years laser therapy has been the standard treatment for proliferative diabetic retinopathy (PDR), but now Australian ophthalmologists have a new option following regulatory approval of an existing drug.Read More Myles HumeSeptember 22, 2020, 8:16 amSeptember 22, 2020